AG vs mFOLFIRINOX as Neoadjuvant Therapy for Borderline Reseactable and Locally Advanced Pancreatic Cancer

Clinical trial NCT04617821 · UNKNOWN

Trial details

NCT number: NCT04617821
Sponsor: Fudan University
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Borderline Resectable Pancreatic Cancer Locally Advanced Pancreatic Adenocarcinoma

Start date: 2021-09-01
Primary completion: 2024-09-01
Enrollment: 300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.